Increase/Decrease in Cash: The total change in cash for the company over the given period.
Thermo Fisher Scientific Inc. (TMO) had Increase/Decrease in Cash of $5.84B for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$44.56B |
|
$6.70B |
|
$26.05B |
|
$18.51B |
|
$36.81B |
|
$7.75B |
|
$-438.00M |
|
$7.31B |
|
$7.31B |
|
$6.76B |
|
$6.72B |
|
$6.72B |
|
$6.76B |
|
$7.75B |
|
$10.53B |
|
377.00M |
|
378.00M |
|
$17.77 |
|
$17.74 |
|
| Balance Sheet Financials | |
$28.71B |
|
$10.56B |
|
$81.64B |
|
$110.34B |
|
$15.19B |
|
$35.85B |
|
$41.74B |
|
$56.93B |
|
-- |
|
$-11.79B |
|
$53.41B |
|
-- |
|
| Cash Flow Statement Financials | |
$7.82B |
|
$-4.05B |
|
$1.80B |
|
$4.04B |
|
$9.88B |
|
|
Increase/Decrease in Cash |
$5.84B |
-- |
|
$-636.00M |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|